Table 3

Antimicrobial susceptibilities of the P. aeruginosa control isolates and 27 patient isolates measured by Etest

IsolateMIC (μg/ml)a
SMX-TMPSXTLcATTZMPIPAKTMCI
PA-ATCC 27853>32>1,02416161.50.25230.50.19
PAmucQC>32>1,024
PA141612816310.125120.380.094
PA14 (mexR)>32>1,024481631.51.530.50.38
PA14 (mexA)0.19060.380.190.50.0470.751.50.380.032
PA14 (oprM)0.25060.50.250.750.04711.50.380.016
PA14 (mexZ)>32>1,024
PA-A10.7516>25616>2560.51.5>256640.5
PA-A20.2531.50.250.750.0941.51620.38
PA-A31480.380.190.750.0320.5121.51
PA-A40.5121.50.510.0641.54840.094
PA-A50.38120.750.750.50.0640.384830.38
PA-A6>32>1,024>256123>32123230.75
PA-A7>32>1,024>2561230.51.53240.38
PA-A80.53961223>32>256244
PA-A9>32>1,024>256122>32>323230.19
PA-A100.5121.50.51.581.5>25680.38
PA-A110.5160.50.190.50.0640.38>25640.25
PA-B1>32>1,02416420.75320.380.125
PA-B28648340.190.753230.5
PA-B332430.251.50.09423240.75
PA-B4451216420.2523280.38
PA-B51120.50.2520.0640.38>256320.5
PA-B636412220.38281.50.5
PA-B764831.50.750.0640.51220.19
PA-B80.75320.50.251.50.0940.38>256320.5
PA-B9>32>1,0248230.190.754841
PA-C10.7501610.190.750.191.5120.750.75
PA-C2>32>1,024>25624>2566>32>25619216
PA-C32.000320.50.511.5>32241.50.5
PA-C4>32>1,024>2566>2564>32>256646
PA-C51.500481.5111.5>32241.50.75
PA-C6>32>1,02448 F6616 f>32>256>1,0244
PA-C70.38032>25632>256>32>32>256192>32
  • a SMX-TMP, sulfamethoxazole-trimethoprim; SX, sulfisoxazole; TLc, ticarcillin-clavulanate; AT, aztreonam; TZ, ceftazidime; MP, meropenem; IP, imipenem; AK, amikacin; TM, tobramycin; CI, ciprofloxacin.